Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 5/20 | 0.33 |
| ▸ | PPARA | Q07869 | 5/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | PPARD | Q03181 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | CASP1 | P29466 | 1/20 | 0.31 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.31 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.31 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.31 |
| ▸ | ESR1 | P03372 | 1/20 | 0.30 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.30 |
| ▸ | CA1 | P00915 | 1/20 | 0.30 |
| ▸ | CA2 | P00918 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2475284 | 0.79 | CA1 (0.50) | ALDH1A1HPGDTSHRMAPK1CASP1 | |
| SCHEMBL517925 | 0.78 | CA1 (0.50) | ALDH1A1CA1CA2 | |
| SCHEMBL2472528 | 0.76 | CA1 (0.49) | ALDH1A1HPGDTSHRMAPK1CASP1 | |
| SCHEMBL12214801 | 0.74 | CA1 (0.44) | PPARGPPARACYP2C9CYP2C19PPARD | |
| SCHEMBL3455207 | 0.72 | — | — | |
| SCHEMBL4267634 | 0.72 | PPARG (0.33) | PPARGPPARACYP2C9CYP2C19PPARD | |
| SCHEMBL1128777 | 0.71 | ESR1 (0.36) | CYP2C9CYP2C19ALDH1A1TSHRHIF1A | |
| SCHEMBL1129059 | 0.71 | CA1 (0.45) | PPARACYP2C9ALDH1A1L3MBTL1CA1 | |
| SCHEMBL6607430 | 0.70 | ENPP2 (0.41) | TSHRCA1CA2 | |
| SCHEMBL8512024 | 0.70 | ESR2 (0.60) | CYP2C9CYP2C19ALDH1A1HPGDTSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-RE47654-E1 | Organic electroluminescence device | IDEMITSU KOASN CO., LTD. (JP) | 2019-10-22 | — | — | US | disclosed |
| EP-2524913-B1 | NITROGENATED HETEROCYCLIC RING DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME | IDEMITSU KOSAN CO (JP) | 2017-07-26 | — | — | EP | disclosed |
| EP-3192789-A1 | NITROGENATED HETEROCYCLIC RING DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME | Idemitsu Kosan Co., Ltd. (JP) | 2017-07-19 | — | — | EP | disclosed |
| US-9126943-B2 | Nitrogenated heterocyclic ring derivative and organic electroluminescent element comprising same | IDEMITSU KOSAN CO., LTD. (JP) | 2015-09-08 | — | — | US | disclosed |
| EP-2525425-B1 | ORGANIC ELECTROLUMINESCENT ELEMENT | IDEMITSU KOSAN CO (JP) | 2014-10-15 | — | — | EP | disclosed |
| US-8803420-B2 | Organic electroluminescence device | IDEMITSU KOSAN CO., LTD. (JP) | 2014-08-12 | — | — | US | disclosed |
| EP-2524913-A1 | NITROGENATED HETEROCYCLIC RING DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME | Idemitsu Kosan Co., Ltd. (JP) | 2012-11-21 | — | — | EP | disclosed |
| EP-2525425-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT | Idemitsu Kosan Co., Ltd. (JP) | 2012-11-21 | — | — | EP | disclosed |
| US-20120153268-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2012-06-21 | — | — | US | disclosed |
| US-20120132899-A1 | NITROGENATED HETEROCYCLIC RING DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2012-05-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120132899-A1 | NITROGENATED HETEROCYCLIC RING DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME | H1-2, L1CAM, H1-0 | PPARG 2491/4885PPARA 2750/4885CYP2C9 1730/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.